Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-9.40	166.19	183.44
Graham Fair Price	-10.65	2.81	3.15
PEG	-87.59	-2.89	23.25
Price/Book	-19.71	2.51	3.13
Price/Cash Flow	52.27	-21.40	-44.83
Prices/Earnings	3.80	61.72	59.46
Price/Sales	-10.94	7.14	8.02
Price/FCF	52.27	-21.40	-44.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-58.57	0.10	0.23
Operating Margin	-10.94	0.03	0.04
ROA	-13.68	< 0.005	< 0.005
ROE	0.01	0.01	-22.65
ROIC	< 0.005	< 0.005	-31.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.35	0.29	17.87
Dividends QOQ	0.07	-0.47	565.02
EBIT QOQ	0.16	-0.18	13.60
EPS QOQ	0.03	-0.21	736.50
FCF QOQ	0.13	-0.71	457.12
Revenue QOQ	-0.03	-0.08	-148.13
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	11.80	20.85	76.67
Days Sales Outstanding (DSO)	21.59	15.40	-28.67
Inventory Turnover	7.63	4.32	-43.40
Debt/Capitalization	0.22	0.15	-30.77
Quick Ratio	1.63	1.38	-15.40
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.79	5.88	1.59
Cash	3.04	1.71	-43.77
Capex	-0.38	-0.62	-62.39
Free Cash Flow	-0.40	-0.69	-70.90
Revenue	2.26	2.07	-8.41
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.85	1.94	4.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-15.54	-7.45	52.03
Naive Interpretation	Member

06 - Financial Health · Weak

Rating